The trial findings suggest that [64Cu]Cu-SAR-BBNPET-CT is a safe imaging technique with potential diagnostic significancein metastatic ER+/PR+/HER2– breast cancer, specifically inthe lobular subtype. This evidence concerns the gene ERBB2 and breast cancer.